These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 19898505)
1. The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis. Xu LP; Liu KY; Liu DH; Chen H; Han W; Chen YH; Wang Y; Huang XJ Bone Marrow Transplant; 2010 Jun; 45(6):985-92. PubMed ID: 19898505 [TBL] [Abstract][Full Text] [Related]
2. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
3. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
4. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
5. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia. Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032 [TBL] [Abstract][Full Text] [Related]
6. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704 [TBL] [Abstract][Full Text] [Related]
7. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors. Zhao XY; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ Bone Marrow Transplant; 2009 Dec; 44(11):721-8. PubMed ID: 19377516 [TBL] [Abstract][Full Text] [Related]
8. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia]. Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931 [TBL] [Abstract][Full Text] [Related]
10. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551 [TBL] [Abstract][Full Text] [Related]
11. Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia. Zhang C; Zhang X; Chen XH; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Wang QY Transfus Apher Sci; 2011 Jun; 44(3):249-55. PubMed ID: 21550308 [TBL] [Abstract][Full Text] [Related]
12. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
13. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312 [TBL] [Abstract][Full Text] [Related]
14. HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome. Chen Y; Liu K; Xu L; Chen H; Liu D; Zhang X; Shi H; Han W; Wang Y; Zhao T; Wang J; Wang J; Huang X Bone Marrow Transplant; 2010 Aug; 45(8):1333-9. PubMed ID: 20062100 [TBL] [Abstract][Full Text] [Related]
15. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482 [TBL] [Abstract][Full Text] [Related]
16. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
17. [Haploidentical allogeneic bone marrow stem cell transplantation combined with peripheral blood stem cells for therapy of leukemia]. Yan HM; Xue M; Wang ZD; Zhu L; Liu J; Ding L; Pan SP; Duan LN; Wang HX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1330-4. PubMed ID: 19840477 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Wang Y; Liu DH; Liu KY; Xu LP; Zhang XH; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Sun YQ; Huang XJ Cancer; 2013 Mar; 119(5):978-85. PubMed ID: 23097265 [TBL] [Abstract][Full Text] [Related]
19. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956 [TBL] [Abstract][Full Text] [Related]
20. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]